(1aR,3S,4S,6Z,9S,15bR)-1a,8,9,15b-テトラヒドロ-3,4,12-トリヒドロキシ-9-メチル-14-メトキシ-3H-オキシレノ[k][2]ベンゾオキサシクロテトラデシン-5,11(2H,4H)-ジオン

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

• 危険有害性情報

  H302：飲み込むと有害

(1aR,3S,4S,6Z,9S,15bR)-1a,8,9,15b-テトラヒドロ-3,4,12-トリヒドロキシ-9-メチル-14-メトキシ-3H-オキシレノ[k][2]ベンゾオキサシクロテトラデシン-5,11(2H,4H)-ジオン 価格

(1aR,3S,4S,6Z,9S,15bR)-1a,8,9,15b-テトラヒドロ-3,4,12-トリヒドロキシ-9-メチル-14-メトキシ-3H-オキシレノ[k][2]ベンゾオキサシクロテトラデシン-5,11(2H,4H)-ジオン 化学特性,用途語,生産方法

• 使用

  Hypothemycin is a potent and selective inhibitor of threonine/tyrosine-specific kinase, MEK, and other protein kinases that contain a conserved cysteine residue in the ATP-binding site in in vitro studies.

• 一般的な説明

  A cell-permeable cis-enone resorlic acid lactone (RAL) and (5Z)-7-Oxozeaenol (Cat. No. 499610) analog that inhibits several kinases via an initial affinity binding to the ATP pocket, followed by a covalent adduct formation with a conserved ATP site cysteine residue of the targeted enzymes, including, but not limited to, Flt1/VEGFR-1, Flt3, cKit(D816V), MAPK1, MAPK2, MEK1, MKK6, PKCμ, PKD2, PRAK, and Tak1 (≥90% inhibition at 2 μM). Hypothemycin is also reported to inhibit two non-RAL targets (99% and 82% inhibition of TrkA and TrkB, respectively, at 2 μM), while one of the 46 putative cis-enone RALs targets, namely GSK-3α, is shown not to be affected. Hypothemycin inhibits multiple kinases involved in MAP kinase pathways and is therefore particularly effective in inhibiting BRAF(V600E)-dependent tumor growth. (5Z)-Zeaenol (Cat. No. 499609) may serve as a negative control.

• Biochem/physiol Actions

  Hypothemycin, one of the highly oxygenated analogues in the group of 14-membered resorcylic acid lactones (RAL), has minor antifungal and cytotoxic activity and exhibits an in vitro anti-malarial activity with an IC50 of 2.2 μg/mL. Hypothemycin is also reported to selectively and irreversibly inhibit protein kinases that contain a conserved cysteine residue (Cys166) that is located within the ATP-binding domain. Though this group accounts for less then 10% of all identified kinases, there are several targets implicated in aberrant cellular proliferation such as ERKs, MEK, FMS-like tyrosine kinase protein (FLT), and platelet-derived growth factor receptors (PDGFR). In cell culture, hypothemycin displays potent cytotoxicity against cancer cell lines that are dependent on certain activating kinase mutations. Additionally, hypothemycin demonstrates significant tumor growth inhibition in at least three separate murine xenograft models. Hypothemycin also inhibits the production of several cytokines such as IL2, IL6, IFNγ, and TNFα.

(1aR,3S,4S,6Z,9S,15bR)-1a,8,9,15b-テトラヒドロ-3,4,12-トリヒドロキシ-9-メチル-14-メトキシ-3H-オキシレノ[k][2]ベンゾオキサシクロテトラデシン-5,11(2H,4H)-ジオン 生産企業

Global(32)Suppliers

76958-67-3, (1aR,3S,4S,6Z,9S,15bR)-1a,8,9,15b-テトラヒドロ-3,4,12-トリヒドロキシ-9-メチル-14-メトキシ-3H-オキシレノ[k][2]ベンゾオキサシクロテトラデシン-5,11(2H,4H)-ジオン キーワード